文献速递主动脉疾病外周动脉疾病

新型自膨式覆膜支架联合分支支架移植物的中期结果:来自意大利多中心登记研究的洞见

Midterm results on a new self-expandable covered stent combined with branched stent grafts: Insights from a multicenter Italian registry.
PubMed 文献 · J Vasc Surg · 2023-02-22

COvera in BRAnch登记研究是一项由医生发起的多中心、双向性、观察性登记研究,纳入284例在24个中心接受多分支腔内修复或髂分支装置联合Bard Covera Plus覆膜支架治疗的患者(共708条靶血管)。围术期技术桥接成功率为98%,随访中位32个月时分支不稳定发生率为1%,1、2、3年主要通畅率分别为99%、99%、97%。结论认为该覆膜支架联合分支内移植物安全可行,中期分支不稳定率低,但需与其他市售覆膜支架开展对比研究。

要点

  • 围术期技术桥接成功率为98%,围术期死亡8例(3%)。
  • 中位随访32个月时分支不稳定发生率为1%。
  • 1、2、3年主要通畅率分别为99%、99%、97%。

核心结论

  • 该新型自膨式覆膜支架联合分支内移植物安全可行,技术成功率高,中期随访分支不稳定率低。
  • 作者认为需要与其他市售覆膜支架开展对比研究。

研究设计与样本

  • COvera in BRAnch登记研究是一项由医生发起的多中心、双向性、观察性登记研究(ClinicalTrials.gov标识符:NCT04598802)。
  • 纳入284例患者(76岁;范围70-80岁;79%为男性),来自24个中心,共治疗708条靶血管。
  • 覆膜支架联合现成支架移植物556条血管(79%),联合定制支架移植物152条(21%)。
  • 在277条血管(39%)中置入307枚辅助内衬支架,其中近端116枚(38%)、支架内66枚(21%)、远端125枚(41%)。

主要发现

  • 当落点在血管分支而非主干时辅助内衬支架置入更频繁(59% vs 39%;P = .031)。
  • 经皮入路时辅助内衬支架置入更频繁(49% vs 35%;P < .001)。
  • 使用直径8 mm或以上支架时辅助内衬支架置入更频繁(44% vs 36%;P = .032)。
  • 使用长度80 mm或以上支架时辅助内衬支架置入更频繁(65% vs 55%;P = .005)。
  • 未行后扩张时辅助内衬支架置入更频繁(45% vs 29%;P < .001);使用内分支构型时更频繁(55% vs 35%;P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the technical periprocedural and midterm outcomes of endovascular repairs with multibranched endovascular repair or iliac branch devices combined with a new self-expanding covered stent. METHODS: The COvera in BRAnch registry is a physician-initiated, multicenter, ambispective, observational registry (ClinicalTrials.gov Identifier: NCT04598802) enrolling patients receiving a multibranched endovascular repair or iliac branch devices procedure mated with Bard Covera Plus (Tempe, AZ) covered stent, designed to evaluate the outcomes of the covered stent mated with patient-specific and off-the-shelf branched stent graft. Primary end points were technical success, branch instability, and freedom from aortic and branch-related reintervention within 30 days and at follow-up. Preoperative characteristics, comorbidities, and outcomes definitions were graded according to the Society for Vascular Surgery reporting standards. RESULTS: Two hundred eighty-four patients (76 years; range, 70-80 years; 79% males) in 24 centers were enrolled for a total of 708 target vessels treated. The covered stents were mated with an off-the-shelf graft in 556 vessels (79%) and a custom-made graft in 152 (21%). Three hundred seven adjunctive relining stents in 277 vessels (39%) were deployed, of which 116 (38%) were proximal, 66 (21%) intrastent, and 125 (41%) distal. Adjunctive relining stent placement was more frequent when landing in a vessel branch instead of the main trunk (59% vs 39%; P = .031), performing a percutaneous access (49% vs 35%; P < .001), using a stent with a diameter of 8 mm or greater (44% vs 36%; P = .032) and a length of 80 mm or greater (65% vs 55%; P = .005), when a post-dilatation was not performed (45% vs 29%; P < .001) and when an inner branch configuration was used (55% vs 35%; P < .001). Perioperative technical bridging success was 98%. Eight patients (3%) died in the perioperative period. Two deaths (1%) were associated with renal branch occlusion followed by acute kidney injury and paraplegia. Follow-up data were available for 638 vessels (90%) at a median of 32 months (Q1, Q3, 21, 46). Branch instability was reported in 1% of branches. Forty-six patients (17%) died during follow-up, nine (3%) of them owing to aortic-related causes. Primary patency rates at 1, 2, and 3 years were 99% (581/587), 99% (404/411), and 97% (272/279), respectively. Branch instability was associated with patient-specific devices (9% vs 4%; P = .014) and intrastent adjunctive stent placement (12% vs 2%; P = .003), especially when a bare metal balloon-expandable stent was used (25% vs 3%; P < .001). CONCLUSIONS: The use of this new self-expanding covered stent mated with branched endografts proved to be safe and feasible with high technical procedural success rates. Low rates of branch instability were observed at midterm follow-up. Comparative studies with other commercially available covered stents are warranted.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bertoglio L, Grandi A, Veraldi GF, et al. Midterm results on a new self-expandable covered stent combined with branched stent grafts: Insights from a multicenter Italian registry. J Vasc Surg. 2023. PMID: 36822256. doi:10.1016/j.jvs.2023.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。